Maxillary Sinus
Conditions
Keywords
maxillary sinus elevation and PEEK
Brief summary
comparison between the resulted bone during maxillary sinus elevation by PEEK with and without platelet rich fibrin
Detailed description
Histomorphometric and clinical analysis of the bone formed after 6 months after the maxillary sinus elevation using PEEK in the 2 groups : the study group (PEEK with platelet rich fibrin) and the control group (PEEK alone ) .
Interventions
platelet rich fibrin
Polyether ether ketone
Sponsors
Study design
Intervention model description
use of platelet rich fibrin after maxillary sinus elevation using PEEK
Eligibility
Inclusion criteria
* • Posterior edentulous ridges with pneumatized maxillary sinus and remaining bone height less than 4 mm. * ASA physical status I and II. * Patients willing to be a part of the study and ready to give their consent in writing for the same. * Patient not complain from maxillary sinusitis * Patient with good oral hygiene. * Both males as well as females without any active periodontal disease. * The edentulous ridges are covered with optimal thickness of mucoperiosteum with no signs of inflammation, ulceration or scar tissue. * Remaining natural teeth have good periodontal tissue support and occlusion showed sufficient inter arch space for future prosthesis.
Exclusion criteria
* • General contraindications to implant surgery. * Untreated gingivitis, periodontitis. * Subjected to irradiation in the head and neck area less than 1 year before implantation. * Untreated periodontitis. * Pregnant or nursing. * Unable to open mouth sufficiently to accommodate the surgical tooling. * Patients participating in other studies, if the present protocol could not be properly followed. * Patient who could/would not participate in the follow-up period.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Bone quantity | 6 months postoperatively | using of CBCT |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Bone quality | 6 months postoperatively | Histomorphometic analysis (For Core biopsy) |
Countries
Egypt